Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
This study is ongoing, but not recruiting participants.
Study NCT00377637   Information provided by Hoffmann-La Roche
First Received: September 15, 2006   Last Updated: August 26, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lupus Nephritis
Additional conditions recognized in this trial
Nephritis
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Glomerulonephritis
Immune System Diseases
Kidney Diseases
Lupus Erythematosus, Systemic
Urologic Diseases
Interventions listed in this trial
mycophenolate mofetil [CellCept]
Cyclophosphamide
Azathioprine
Additional drug interventions recognized in this trial
Mycophenolate mofetil
Mycophenolic Acid
More general drug interventions related to this trial
Alkylating Agents
Antibiotics, Antineoplastic
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Hoffmann-La Roche
Aspreva Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services